Biosensors and Bioelectronics Centre, Department of Physics, Chemistry and Biology (IFM), Linköping University, S-58183 Linköping, Sweden; University of Sousse, Higher Institute of Applied Sciences and Technology of Sousse, GREENS-ISSAT, Cité Ettafala, 4003 Ibn Khaldoun Sousse, Tunisia.
Biosensors and Bioelectronics Centre, Department of Physics, Chemistry and Biology (IFM), Linköping University, S-58183 Linköping, Sweden.
Biosens Bioelectron. 2017 Jun 15;92:154-161. doi: 10.1016/j.bios.2017.02.014. Epub 2017 Feb 10.
Alteration in expression of miRNAs has been correlated with different cancer types, tumour stage and response to treatments. In this context, a structurally responsive oligonucleotide-based electrochemical impedimetric biosensor has been developed for the simple and sensitive detection of miRNA-21. A highly specific biotinylated DNA/LNA molecular beacon (MB) probe was conjugated with gold nanoparticles (AuNPs) to create an integrated, dual function bio-label (biotin-MB-AuNPs) for both biorecognition and signal generation. In the presence of target miRNA-21, hybridisation takes place resulting in the "activation" of the biotin-MB; this event makes the biotin group, which was previously "protected" by the steric hindrance of the MB stem-loop structure, accessible. The activated biotin-MB-AuNPs/miRNA complexes become available for capture, via supramolecular interaction, onto a nentravidin-modified electrode for electrochemical transduction. The binding event results in a decrease of the charge transfer resistance at the working electrode/electrolyte interface. The biosensor responded linearly in the range 1-1000 pM of miRNA-21, with a limit of detection of 0.3 pM, good reproducibility (Relative Standard deviation (RSD) =3.3%) and high selectivity over other miRNAs (i.e. miRNA-221 and miRNA-205) sequences. Detection of miRNA-21 in spiked serum samples at clinically relevant levels (low pM range) was also demonstrated, thus illustrating the potential of the biosensor for point-of-care clinical applications. The proposed biosensor design, based on the combination of a neutravidin transducing surface and the dual-function biotin-MB-AuNPs bio-label, provides a simple and robust approach for detection of short-length nucleic acid targets, such as miRNAs.
miRNA 表达的改变与不同的癌症类型、肿瘤分期和治疗反应有关。在这种情况下,已经开发出一种基于结构响应的寡核苷酸电化学阻抗生物传感器,用于简单、灵敏地检测 miRNA-21。将高度特异性的生物素化 DNA/LNA 分子信标 (MB) 探针与金纳米粒子 (AuNPs) 缀合,以创建用于生物识别和信号生成的集成、双重功能生物标记物(生物素-MB-AuNPs)。在存在靶 miRNA-21 的情况下,杂交发生导致“激活”生物素-MB;该事件使先前被 MB 茎环结构的空间位阻“保护”的生物素基团变得可用。激活的生物素-MB-AuNPs/miRNA 复合物可通过超分子相互作用被捕获到修饰有链霉亲和素的电极上进行电化学转换。结合事件导致工作电极/电解质界面处的电荷转移电阻降低。该生物传感器在 1-1000 pM miRNA-21 的范围内呈线性响应,检测限为 0.3 pM,具有良好的重现性(相对标准偏差 (RSD) =3.3%),并且对其他 miRNA(即 miRNA-221 和 miRNA-205)序列具有高选择性。还在临床相关水平(低 pM 范围内)的血清样本中检测到 miRNA-21,从而说明了该生物传感器在即时护理临床应用中的潜力。基于链霉亲和素转导表面和双重功能生物素-MB-AuNPs 生物标记物的组合的生物传感器设计为短长度核酸靶标(如 miRNA)的检测提供了一种简单、稳健的方法。